Tuberculosis of lung
Chapter 1:Certain infectious and parasitic diseases
ICD-10 A15.0 is a billable code used to indicate a diagnosis of tuberculosis of lung.
Tuberculosis of the lung, classified under ICD-10 code A15.0, is a contagious bacterial infection caused by Mycobacterium tuberculosis. It primarily affects the lungs but can also spread to other parts of the body. The disease is characterized by symptoms such as persistent cough, chest pain, hemoptysis (coughing up blood), fever, night sweats, and weight loss. Diagnosis typically involves a combination of clinical evaluation, chest X-rays, and microbiological tests, including sputum smear microscopy and culture for Mycobacterium tuberculosis. The treatment regimen usually consists of a multi-drug therapy over a period of at least six months, which may include isoniazid, rifampicin, ethambutol, and pyrazinamide. Monitoring for drug resistance is crucial, as multi-drug resistant tuberculosis (MDR-TB) poses significant treatment challenges. Public health measures, including contact tracing and isolation of infectious patients, are essential to control the spread of tuberculosis. The disease remains a major global health concern, particularly in areas with high prevalence and limited healthcare resources.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with chronic cough, hemoptysis, or abnormal chest X-ray findings.
Ensure accurate documentation of sputum test results and any drug resistance patterns.
Comprehensive history of exposure, travel, and previous tuberculosis treatment.
Patients with a history of tuberculosis exposure or those presenting with atypical symptoms.
Document any public health interventions, such as contact tracing and isolation measures.
Used for screening individuals at high risk for tuberculosis.
Document the reason for testing and results.
Pulmonologists and infectious disease specialists should ensure proper interpretation of results.
Ordered to evaluate suspected pulmonary tuberculosis.
Include clinical indications and findings.
Radiologists should provide detailed reports to assist in diagnosis.
Key symptoms include a persistent cough lasting more than three weeks, chest pain, hemoptysis, fever, night sweats, and unexplained weight loss.
Diagnosis typically involves a combination of clinical evaluation, chest X-rays, and microbiological tests such as sputum smear and culture.
The standard treatment involves a multi-drug regimen, typically including isoniazid, rifampicin, ethambutol, and pyrazinamide, administered over a minimum of six months.
Tuberculosis is a contagious disease, and public health measures such as contact tracing, isolation of infectious patients, and monitoring for drug resistance are critical to controlling its spread.
